HALEON Pharmaceuticals: Major
Health Technology
Mkt Cap
89.0B
P/E (TTM)
13.58
EPS
54.45
ROE
50.11%
Div Yield
3.95%
About
Haleon Pakistan Ltd. engages in the manufacturing, marketing, and sale of consumer healthcare products. It is also involved in research and development of innovative products in three primary areas of pharmaceuticals, vaccines, and consumer healthcare. The company was founded on March 31, 2015 and is headquartered in Karachi, Pakistan.
Financial Highlights
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Revenue | 43.11B | 37.21B | 31.61B | 27.51B | 24.16B | |
| Gross Profit | 16.09B | 12.22B | 6.22B | 4.67B | 6.45B | |
| Net Income | 6.37B | 4.58B | 995.59M | 325.41M | 2.13B | |
| EPS | 54.45 | 39.11 | 8.51 | 2.78 | 18.23 | |
| ROE | 47.59% | 45.76% | 13.22% | 4.73% | 35.93% | |
| ROA | 25.71% | 22.57% | 5.89% | 2.22% | 17.08% | |
| Gross Margin | 37.33% | 32.86% | 19.67% | 16.98% | 26.69% | |
| Net Margin | 14.78% | 12.31% | 3.15% | 1.18% | 8.83% | |
| Current Ratio | 1.57 | 1.54 | 1.32 | 1.42 | 1.46 | |
| DPS | 30.00 | 20.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | 4.28B | 4.48B | 798.69M | 715.06M | 1.24B |